Comprehensive Steroid Assay with Non-Targeted Analysis Using Liquid Chromatography Ion Mobility Mass Spectrometry
Authors:
- Mai YamakawaMYMai Yamakawa
- Shigehiro KarashimaSKShigehiro Karashima
- Riko TakataRTRiko Takata
- Taichi HabaTHTaichi Haba
- Keigo KuroiwaKKKeigo Kuroiwa
- Hideaki TouyamaHTHideaki Touyama
- Atsushi HashimotoAHAtsushi Hashimoto
- Seigo KonishiSKSeigo Konishi
- Daisuke AonoDADaisuke Aono
- Mitsuhiro KometaniMKMitsuhiro Kometani
- Hidetaka NamboHNHidetaka Nambo
- Takashi YonedaTYTakashi Yoneda
Open Access
- 10 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (22) , 13858
Abstract
Aldosterone-producing adenomas (APAs) have different steroid profiles in serum, depending on the causative genetic mutation. Ion mobility is a separation technique for gas-phase ions based on their m/z values, shapes, and sizes. Human serum (100 µL) was purified by liquid–liquid extraction using tert-butyl methyl ether/ethyl acetate at 1/1 (v/v) and mixed with deuterium-labeled steroids as the internal standard. The separated supernatant was dried, re-dissolved in water containing 20% methanol, and injected into a liquid chromatography–ion mobility–mass spectrometer (LC/IM/MS). We established a highly sensitive assay system by separating 20 steroids based on their retention time, m/z value, and drift time. Twenty steroids were measured in the serum of patients with primary aldosteronism, essential hypertension, and healthy subjects and were clearly classified using principal component analysis. This method was also able to detect phosphatidylcholine and phosphatidylethanolamine, which were not targeted. LC/IM/MS has a high selectivity for known compounds and has the potential to provide information on unknown compounds. This analytical method has the potential to elucidate the pathogenesis of APA and identify unknown steroids that could serve as biomarkers for APA with different genetic mutations.Keywords
Funding Information
- JSPS KAKENHI (19K05531, 22K21203)
- Toyama Pharmaceutical Valley Development Consortium
- Mitani Foundation for Research and Development
This publication has 34 references indexed in Scilit:
- Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertensionNature Genetics, 2013
- Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronismNature Genetics, 2013
- Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertensionNature Genetics, 2013
- K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary HypertensionScience, 2011
- Steroid measurement with LC–MS/MS. Application examples in pediatricsThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS)The Journal of Steroid Biochemistry and Molecular Biology, 2010
- Analysis of estrogens in serum and plasma from postmenopausal women: Past present, and futureSteroids, 2010
- Ion mobility mass spectrometry of proteins and proteinassembliesChemical Society Reviews, 2009
- Ion mobility–mass spectrometry analysis of large protein complexesNature Protocols, 2008
- Ion mobility–mass spectrometryJournal of Mass Spectrometry, 2008